RSV Immunization Uptake Data—Province-Wide Collaboration

As part of Ontario’s expanded infant RSV prevention program, BORN Ontario began collecting data in fall 2024 to monitor uptake of nirsevimab and prenatal RSV vaccines across birthing hospitals. This infographic summarizes key findings from the first season of universal RSV immunization, highlighting uptake rates, hospital-level variation, and barriers to implementation.

With approximately 94% of births represented, the data provide a valuable snapshot of how hospitals and care teams are working to protect infants from severe RSV outcomes—and where opportunities remain to improve coverage and equity.